Infections in diabetic foot ulcerations
Tóm tắt
Diabetic foot complications are the largest nontraumatic cause of lower extremity amputations, accounting for almost 90,000 amputations per year. Most of these amputations are the result of infections caused by ulcerations of the foot that are not recognized or treated in an appropriate and timely fashion. Often, cultures are taken when not warranted and antibiotics are administered when no infection is present, causing significant increases in resistant organisms. Although there have been many attempts to classify diabetic foot lesions, none of these systems are specific for infectious complications. This paper presents a system for identifying the presence and severity of infection with suggestions for appropriate empiric antibiotic therapy.
Tài liệu tham khảo
Frykberg RG, Armstrong DG, Giurini J, et al.: Diabetic foot disorders: a clinical practice guideline. American College of Foot and Ankle Surgeons. J Foot Ankle Surg 2000, 39(Suppl 5):S1-S60. This study is one of the first attempts to provide evidence-based treatment guidelines for complications in the diabetic foot. It has an extremely thorough reference list.
Brand PW: Repetitive stress in the development of diabetic foot disorders. In The Diabetic Foot, edn 4. Edited by Levin ME and Davidson JK. St. Louis: Mosby; 1988:83–90.
Lipsky BA, Berendt AR: Principles and practice of antibiotic therapy of diabetic foot infections. Diabetes Metab Res Rev 2000, 16(Suppl 1):S42-S46.
Lavery LA, Walker SC, Harkless LB, et al.: Infected puncture wounds in diabetic and non diabetic adults. Diabetes Care 1995, 18:1588–1591.
Armstrong DA, Lavery LA, Sariaya M, et al.: Leukocytosis is a poor indicator of acute osteomyelitis of the foot in diabetes mellitus. J Foot Ankle Surg 1996, 35:280–283.
Grayson ML, Gibbons GW, Balogh K, et al.: Probing to bone in infected pedal ulcers: a clinical sign of underlying osteomyelitis in diabetic patients. JAMA 1995, 273:721–723.
Bergstrom N, Bennett MA, Carlson CE, et al.: Treatment of Pressure Ulcers. Clinical Practice Guidelines, No 15. Washington, DC: US Department of Health and Human Services; 1994. [ACPR Publication No. 95-0652.].
Joseph WS: Handbook of Lower Extremity Infections, edn 2. St. Louis: Churchill Livingstone; 2003.
Sapico FA, Canawati HN, Witte JL, et al.: Quantitative aerobic and anaerobic bacteriology of the infected diabetic foot. J Clin Microbiol 1980, 12:413–420.
Wagner FW: The dysvascular foot: a system of diagnosis and treatment. Foot Ankle 1981, 2:62–122.
Lavery LA, Armstrong DG, Harkless LB: Classification of diabetic foot wounds. J Foot Ankle Surg 1996, 35:528–531.
Armstrong DG, Lavery LA, Harkless LB: Validation of a diabetic wound classification system: the contribution of depth, infection and vascular disease to the risk of amputation. Diabetes Care 1998, 21:855–859. This paper validates a new and useful wound classification system for diabetic feet. It represents one of the few instances in which this validation has occurred.
Oyibo SO, Jude EB, Tarawneh I, et al.: A comparison of two diabetic foot ulcer classification systems. Diabetes Care 2001, 24:84–88.
MacFarlane RM, Jeffcoate WJ: Classification of diabetic foot ulcers: the S(AD) SAD system. Diabetic Foot 1999, 2:123–132.
Foster A, Edmonds M: Simple staging system: a tool for diagnosis and management. Diabetic Foot 2000, 3:56–62.
Joseph WS: Treatment of lower extremity infections in diabetics. Drugs 1991, 42:984–996.
Lipsky BA: Overview of the diabetic foot: epidemiology, pathophysiology, and the role of infection. Fed Pract 1998, 15:2–8.
Lipsky BA, Litka PA, Zasloff M, et al.: Microbial eradication and clinical resolution of infected diabetic foot ulcers treated with topical MSI-78 vs. oral ofloxacin. Poster presented at the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto; September 28-October 1, 1997.
Lipsky BA: Evidence-based antibiotic therapy of diabetic foot infections. FEMS Immunol Med Microbiol 1999, 26:367–376. This is an excellent review of the literature supporting various antibiotic therapies that have been studied in diabetic patients with foot infections.
LeFrock JL, Blais F, Schell RF, et al.: Cefoxitin in the treatment of diabetic patients with lower extremity infections. Infect Surg 1983, 2:361–374.
Lipsky BA, Pecoraro RE, Larson SA, et al.: Outpatient management of uncomplicated lower extremity infections in diabetic patients. Arch Intern Med 1990, 150:790–797.
Chantelau E, Tanudjaja T, Altenhofer F, et al.: Antibiotic treatment for uncomplicated neuropathic forefoot ulcers in diabetes: a controlled trial. Diabet Med 1996, 13:156–159. Although a relatively small trial, this study supports the contention that antibiotic therapy is not useful in clinically noninfected ulcerations.
Tan JS, Friedman NM, Hazelton-Miller C, et al.: Can aggressive treatment of diabetic foot infections reduce the need for above-ankle amputation? Clin Infect Dis 1996, 23:286–291. This study emphasizes the importance of early surgical consultation for debridement and removal of dead tissues with appropriate antimicrobial therapy to reduce above-ankle amputation.